Transgene S.A. | Ownership
Companies that own Transgene S.A.
OFI Asset Management SA
835,754
1.34%
0
0.06%
05/31/2018
La Banque Postale Asset Management SA
183,076
0.28%
0
0%
06/29/2018
Peacock Capital GmbH
75,000
0.12%
75,000
0.49%
11/30/2017
AIPM Azur International Portfolio Management AG
44,400
0.07%
0
0.69%
12/31/2017
Lampe Asset Management GmbH
24,000
0.04%
0
0.01%
06/29/2018
RAM Active Investments SA
17,311
0.03%
17,311
0%
06/30/2017
J. de Demandolx Gestion SA
15,903
0.03%
4,930
0.56%
06/30/2017
Baader Bank AG (Investment Management)
12,584
0.02%
-373
0.02%
06/29/2018
Rothschild Asset Management SCS
8,280
0.01%
-7,185
0%
12/31/2015
Allianz Global Investors GmbH (France)
6,709
0.01%
-4,554
0%
12/31/2015
| Address |
400 Boulevard Gonthier dAndernach
Strasbourg Alsace 67405
France
|
|
Employees
|
- |
| Website |
http://www.transgene.fr |
| Updated |
07/08/2019 |
| Transgene SA is a biotechnology company, which engages in the research, development, and manufacture of immunotherapies for the treatment of cancer and infectious diseases. Its products include TG4010, Pexa-Vec, TG4001, TG6002, TG1050, and TG4040. The company was founded in December 1979 and is headquartered in Strasbourg, France. |
